December 24, 2024 07:57 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people | Kuwait PM personally sees off Modi at airport as Indian premier concludes two-day trip | Three pro-Khalistani terrorists, who attacked a police outpost in Gurdaspur, killed in an encounter | Who is Sriram Krishnan, an Indian-American picked by Donald Trump as US AI policy advisor? | Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait
Dr Reddy's Lab Sept qtr net profit down 9.5% to Rs 13.42 billion

Dr Reddy's Lab Sept qtr net profit down 9.5% to Rs 13.42 billion

Nov 06, 2024, at 05:02 am

Hyderabad: Dr. Reddy's Laboratories, an Indian generic pharmaceutical company, announced on Tuesday that its second-quarter profits were impacted by one-time charges associated with its joint venture with Nestlé India and the acquisition of Nicotinell, reported Reuters

Dr Reddy’s Lab Q4FY24 net profit up 36% YoY to Rs 1,307 cr

Dr Reddy’s Lab Q4FY24 net profit up 36% YoY to Rs 1,307 cr

May 07, 2024, at 11:57 pm

Mumbai: Hyderabad-based pharma major Dr Reddy’s Laboratories recorded a net profit of Rs 1,307 crore in the March quarter of FY24, up 36 percent from the same period last year when it reported a profit of Rs 960 crore.

Dr Reddy's Q4FY23 consolidated PAT jumps 996 pc YoY to Rs 959 cr

Dr Reddy's Q4FY23 consolidated PAT jumps 996 pc YoY to Rs 959 cr

May 11, 2023, at 07:51 am

Hyderabad: Hyderabad-based Pharma giant Dr Reddy’s Lab on Wednesday reported a consolidated net profit of Rs 959 crore for the fourth quarter ended March 2023, up 996 percent over Rs 87.5 crore reported in the corresponding quarter in the previous year.